Abstract |
Golden hamsters received Adriamycin (ADR), detorubicin (DTR), AD-32, or aclacinomycin (ACM) three times weekly at doses extrapolated from optimal doses in L1210 leukemia. Minimal early lesions of the myocardium were detected by electron microscopy in ACM-treated animals. These lesions were aggravated after several weeks of treatment but remained reversible. Lesions in AD-32-treated hamsters were slightly more marked than those seen in ACM-treated animals but were much less severe than those observed in ADR- or DTR-treated animals. Similarly, light microscopy revealed pathologic changes in the skin following ADR or DTR administration. These changes were not seen in animals receiving AD-32 or ACM.
|
Authors | D Dantchev, V Slioussartchouk, M Paintrand, M Hayat, C Bourut, G Mathé |
Journal | Cancer treatment reports
(Cancer Treat Rep)
Vol. 63
Issue 5
Pg. 875-88
(May 1979)
ISSN: 0361-5960 [Print] United States |
PMID | 455329
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Antibiotics, Antineoplastic
- Naphthacenes
- aclacinomycins
- valrubicin
- Aclarubicin
- Doxorubicin
- Daunorubicin
|
Topics |
- Aclarubicin
(analogs & derivatives)
- Animals
- Antibiotics, Antineoplastic
(adverse effects)
- Cricetinae
- Daunorubicin
(administration & dosage, analogs & derivatives)
- Doxorubicin
(administration & dosage, adverse effects, analogs & derivatives)
- Drug Administration Schedule
- Heart
(drug effects)
- Leukemia L1210
(drug therapy)
- Mesocricetus
- Microscopy, Electron
- Myocardium
(ultrastructure)
- Naphthacenes
(administration & dosage, adverse effects)
- Skin
(drug effects, pathology)
|